Latest Breaking News On - Anthonyb el khoueiry - Page 1 : comparemela.com

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm

Experts discuss updated findings from key clinical trials in hepatocellular carcinoma presented during the 2024 Gastrointestinal Cancers Symposium.

United statesJun gongAnthonyb el khoueiryRachnat shroffMichael morseEuropean society for medical oncology asia congressOnclive peer exchangeSystemic therapyEuropean societyMedical oncology asia congressSecond line advancedNew england journalAsco giHepatocellular carcinomaIanne coveyAnwaar saeed

Abstract 1574238: Intratumoral INT230-6 (Cisplatin, Vinblastine, Shao) Alone or with Ipilimumab Prolonged Survival with Favorable Safety and Immune Activation in Adults with Refractory Sarcomas (NCT 03058289) -November 02, 2023 at 10:37 am EDT

Abstract 1574238: INTRATUMORAL INT230-6 ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY AND IMMUNE ACTIVATION IN ADULTS WITH.

United statesNew yorkFox chase cancer centerAnthonyb el khoueiryAnthonyj olszanskiIanb waltersLos angelesLillianl siuDianal hannaChristian frederick meyerMatthew inghamJacob stephen thomasAlbiruni ryan abdul razakLewish benderLuish camachoNilofer saba azaz

Affimed Announces an ASCO Breakthrough Poster Presentation with Clinical Data of AFM24 in Combination with NKGen Biotech s SNK01 NK Cells

Affimed Announces an ASCO Breakthrough Poster Presentation with Clinical Data of AFM24 in Combination with NKGen Biotech s SNK01 NK Cells
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Baden wübergNew yorkUnited statesAnthony el khoueiryAlexander fudukidisAndreas harstrickMary beth sandinAnthonyb el khoueiryNorris comprehensive cancer centerClinical researchUniversity of texas md anderson cancer centerPhasei programAssociate directorPhasei program directorComprehensive cancer centerChief medical officer

Affimed (AFMD) Announces Breakthrough Poster Presentation with Clinical Data of AFM24 in Combination with NKGen Biotech s SNK01 NK Cells

Affimed (AFMD) Announces Breakthrough Poster Presentation with Clinical Data of AFM24 in Combination with NKGen Biotech s SNK01 NK Cells
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Anthonyb el khoueiryAnthony el khoueiryAndreas harstrickPhasei programClinical researchNorris comprehensive cancer centerAssociate directorPhasei program directorComprehensive cancer centerChief medical officerPoster session

Affimed Announces an ASCO Breakthrough Poster Presentation with Clinical Data of AFM24 in Combination with NKGen Biotech s SNK01 NK Cells

Stable disease was observed in three out of seven heavily pretreated patientsNo dose-limiting toxicities or unexpected toxicities were observed HEIDELBERG, Germany, July 31, 2023 Affimed N.V. .

Baden wübergUnited statesNew yorkAnthony el khoueiryAndreas harstrickAnthonyb el khoueiryAlexander fudukidisMary beth sandinPhasei programUniversity of texas md anderson cancer centerNorris comprehensive cancer centerClinical researchAssociate directorPhasei program directorComprehensive cancer centerChief medical officer